Galectin Therapeutics | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Merck USD 48.34B 2.02B 2025-03



Galectin Therapeutics Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.